Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-25-073170
Filing Date
2025-08-01
Accepted
2025-08-01 17:18:45
Documents
1
Effectiveness Date
2025-08-01

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2522275d11_s8pos.htm S-8 POS 37303
  Complete submission text file 0001104659-25-073170.txt   38322
Mailing Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-223146 | Film No.: 251177141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)